Long-Term Safety and Disease Control of Ruxolitinib Cream Among Adolescents With Atopic Dermatitis: Results From Two Phase 3 Studies. J of Skin [Internet]. 2022 Mar. 4 [cited 2025 May 17];6(2):s28. Available from: https://skin.dermsquared.com/skin/article/view/1545